Adults with SAA Needed for Study
NHLBI seeks adults with severe aplastic anemia (SAA) for a research study determining viability and safety of early initiation of oral therapy with cyclosporine and eltrombopag in patients with SAA. All patients will receive standard treatment with cyclosporine, eltrombopag and horse anti-thymocyte-globulin (h-ATG), unless there is complete count recovery with oral therapy. Compensation will be provided. Call the Office of Patient Recruitment, 800-411-1222 (TTY for the deaf or hard of hearing 866-411-1010) and refer to study 20-H-0033. Read more at https://go.usa.gov/xwbDt.